Next Article in Journal
Pre-Hospital ECG E-Transmission for Patients with Suspected Myocardial Infarction in the Highlands of Scotland
Next Article in Special Issue
Effects of Moderate Strength Cold Air Exposure on Blood Pressure and Biochemical Indicators among Cardiovascular and Cerebrovascular Patients
Previous Article in Journal
The Relation between Scores on Noise Annoyance and Noise Disturbed Sleep in a Public Health Survey
Previous Article in Special Issue
Assessment of Unsuspected Exposure to Drugs of Abuse in Children from a Mediterranean City by Hair Testing
Int. J. Environ. Res. Public Health 2014, 11(2), 2328-2345; doi:10.3390/ijerph110202328
Review

Potential for Improved Glycemic Control with Dietary Momordica charantia in Patients with Insulin Resistance and Pre-Diabetes

1,†,* , 2,†
, 3,†
, 4,†
, 5,6,†
 and 5,†
1 East Carolina Heart Institute and the Center for Health Disparities, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA 2 Adult Gerontological Nurse Practitioner Program, School of Nursing, University of North Carolina at Greensboro, Greensboro, NC 27402, USA 3 Department of General Surgery, University of Virginia School of Medicine, Charlottesville, VA 22908, USA 4 Department of Cardiovascular Sciences, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA 5 Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA 6 East Carolina Diabetes and Obesity Institute (ECDOI) at East Carolina University, 115 Heart Drive, East Carolina Heart Institute, Greenville, NC 27834, USA These authors contributed equally to this work.
* Author to whom correspondence should be addressed.
Received: 23 December 2013 / Revised: 2 February 2014 / Accepted: 10 February 2014 / Published: 21 February 2014
(This article belongs to the Special Issue IJERPH: 10th Anniversary)
View Full-Text   |   Download PDF [250 KB, uploaded 19 June 2014]

Abstract

Bitter Melon (Momordica charantia) is a widely used traditional remedy for hyperglycemia. While the medicinal properties of this plant have been studied extensively using in vitro and animal models, the clinical efficacy and safety in humans is largely unknown. This review discusses the benefits and limitations of bitter melon supplementation in the context of epidemic levels of insulin resistance and pre-diabetes throughout the world.
Keywords: Momordica charantia; bitter melon; insulin resistance; pre-diabetes; glycemic control Momordica charantia; bitter melon; insulin resistance; pre-diabetes; glycemic control
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Export to BibTeX |
EndNote


MDPI and ACS Style

Efird, J.T.; Choi, Y.M.; Davies, S.W.; Mehra, S.; Anderson, E.J.; Katunga, L.A. Potential for Improved Glycemic Control with Dietary Momordica charantia in Patients with Insulin Resistance and Pre-Diabetes. Int. J. Environ. Res. Public Health 2014, 11, 2328-2345.

View more citation formats

Related Articles

Article Metrics

Comments

Citing Articles

[Return to top]
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert